Table 1.
Metric | Non-fallers (N=90) | Fallers (N=54) | p-Value |
---|---|---|---|
Age (yrs) | 67.25 (8.08) | 70.81 (7.56) | 0.0228 |
Height (cm) | 172.42 (9.93) | 174.41 (10.03) | 0.1706 |
Weight (kg) | 80.29 (18.75) | 78.94 (14.03) | 0.9897 |
Sex (F/M) | 35/55 | 16/38 | 0.2607 |
Disease Duration (years) | 5.3 (4.1) | 7.6 (5.9) | 0.0241 |
Total LEDD (mg/day) | 577.79 (337.22) | 645.59 (449.11) | 0.5820 |
MDS UPDRS Part II Total Score | 11.9 (6.5) | 16.0 (7.0) | 0.0013 |
MDS UPDRS Part III Total Score | 37.3 (10.9) | 46.2 (13.3) | 0.0001 |
MDS UPDRS Part III PIGD Score | 4.1 (2.6) | 6.5 (3.3) | 0.0000 |
MDS UPDRS Part IV Total Score | 3.04 (3.08) | 3.87 (3.68) | 0.1688 |
MDS UPDRS Total Score | 61.9 (17.5) | 77 (22.2) | 0.0003 |
Hoehn & Yahr scale (stage) | 2.1 (0.5) | 2.5 (0.8) | 0.0011 |
MOCA (score) | 25.9 (3.4) | 25.7 (3.6) | 0.8245 |
NFOGQ Past Month (score) | 0.28 (0.5) | 0.6 (0.5) | 0.0002 |
PDQ39 Total Score (%) | 15.1 (10.5) | 21.4 (12.8) | 0.0055 |
MSD-UPDRS = Movement Disorders Society Unified Parkinson’s Disease Rating Scale; PIGD = Postural Instability and Gait Disorders; NfoGQ = New Freezing of Gait Questionnaire; MOCA = Montreal Cognitive Assessment; LEDD = Levodopa Equivalent Daily Dose; NFOGQ Past Month= First question of NFOGQ for freezing in last month; PDQ39 = Parkinson’s Disease Questionnaire – 39.